Kovack Advisors’s Hims & Hers Health HIMS Stock Holding History

Kovack Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,638	Closed	-$216K	–	1049
2025 Q4	$216K	Buy	+6,638	New	+$284K	0.01%	911

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Defiance ETFs New York $6.98B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kovack Advisors's HIMS Position: Q1 2026 in Review

Kovack Advisors sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 6,638 shares — an estimated $216K sold.

Kovack Advisors first reported a position in HIMS in Q4 2025 and held it in 1 quarter. The position peaked at $216K in Q4 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

Kovack Advisors reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
Kovack Advisors sold 6,638 Hims & Hers Health shares in Q1 2026, an estimated $216K.
Kovack Advisors first reported a position in Hims & Hers Health in Q4 2025 and held it in 1 quarter.
Kovack Advisors's Hims & Hers Health position peaked at $216K in Q4 2025.
434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.